Baseline, Early Changes, and Residual Albuminuria: Post Hoc Analysis of a Randomized Clinical Trial of Dapagliflozin in Chronic Kidney Disease.

ABSTRACT:

SUBMITTER: van Mil D 

PROVIDER: S-EPMC11637702 | biostudies-literature | 2024 Dec

REPOSITORIES: biostudies-literature